BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $266,000 | -19.9% | 1,825 | -34.8% | 0.03% | -13.2% |
Q1 2022 | $332,000 | -15.5% | 2,800 | -1.8% | 0.04% | -11.6% |
Q4 2021 | $393,000 | +5.6% | 2,850 | +6.5% | 0.04% | -4.4% |
Q3 2021 | $372,000 | +61.0% | 2,675 | +12.6% | 0.04% | +60.7% |
Q2 2021 | $231,000 | +1.8% | 2,375 | -10.4% | 0.03% | -12.5% |
Q4 2020 | $227,000 | +104.5% | 2,650 | +22.4% | 0.03% | +68.4% |
Q1 2019 | $111,000 | +38.8% | 2,165 | +0.7% | 0.02% | +18.8% |
Q4 2018 | $80,000 | -1.2% | 2,150 | 0.0% | 0.02% | +14.3% |
Q3 2018 | $81,000 | -12.9% | 2,150 | -8.5% | 0.01% | -17.6% |
Q2 2018 | $93,000 | +78.8% | 2,350 | +17.5% | 0.02% | +70.0% |
Q1 2018 | $52,000 | -17.5% | 2,000 | -14.9% | 0.01% | -16.7% |
Q4 2017 | $63,000 | – | 2,350 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |